067370 — Sun Bio Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSucker Stock

Annual cashflow statement for Sun Bio, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Interim Report	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	—	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	1,202	285	869	4,607	-104
Depreciation
Non-Cash Items	566	4,512	2,202	1,186	71.4
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-304	-2,194	-2,235	-1,763	-114
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	2,310	3,479	1,639	4,969	1,173
Capital Expenditures	-115	-4,477	-18,786	-8,609	-15,873
Purchase of Fixed Assets
Other Investing Cash Flow Items	-7	7,767	-9,955	9,965	6.97
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-122	3,291	-28,741	1,356	-15,866
Financing Cash Flow Items	—	-11.8	240	245	248
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-477	-2,957	21,712	-1,674	15,008
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	1,710	4,032	-5,446	4,651	442